Open-Label Study of ARD-0403 in Testosterone Deficient Men

PHASE3TerminatedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2007

Study Completion Date

June 30, 2008

Conditions
Hypogonadism
Interventions
DRUG

ARD-0403

Daily transdermal ARD-0403

Trial Locations (12)

19104

Hospital of the University of Pennsylvania, Philadelphia

21287

Johns Hopkins University, Baltimore

27706

Duke University Medical Center, Durham

35801

Medical Affiliated Research Center, Inc, Huntsville

77030

Baylor College of Medicine, Houston

90502

Harbor-UCLA Medical Center, Torrance

97239

Oregon Health and Science University, Portland

98493

VA Puget Sound Health Care System, Seattle

94305-5826

Stanford University, Stanford

60611-3008

Northwestern University, Chicago

02114

Massachusetts General Hospital, Boston

78229-4801

dgd Research, San Antonio

Sponsors
All Listed Sponsors
lead

Ardana Bioscience Ltd

INDUSTRY

NCT00562731 - Open-Label Study of ARD-0403 in Testosterone Deficient Men | Biotech Hunter | Biotech Hunter